132 related articles for article (PubMed ID: 26483346)
1. miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.
Tai MC; Kajino T; Nakatochi M; Arima C; Shimada Y; Suzuki M; Miyoshi H; Yatabe Y; Yanagisawa K; Takahashi T
Carcinogenesis; 2015 Dec; 36(12):1464-73. PubMed ID: 26483346
[TBL] [Abstract][Full Text] [Related]
2. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
[No Abstract] [Full Text] [Related]
3. mTORC2 promotes cell survival through c-Myc-dependent up-regulation of E2F1.
Zou Z; Chen J; Liu A; Zhou X; Song Q; Jia C; Chen Z; Lin J; Yang C; Li M; Jiang Y; Bai X
J Cell Biol; 2015 Oct; 211(1):105-22. PubMed ID: 26459601
[TBL] [Abstract][Full Text] [Related]
4. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
6. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y
Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161
[TBL] [Abstract][Full Text] [Related]
7. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
Xiong J; Du Q; Liang Z
Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.
Rothschild SI; Tschan MP; Federzoni EA; Jaggi R; Fey MF; Gugger M; Gautschi O
Oncogene; 2012 Sep; 31(38):4221-32. PubMed ID: 22249264
[TBL] [Abstract][Full Text] [Related]
11. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
13. c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level.
Liu M; Zhu H; Yang S; Wang Z; Bai J; Xu N
Cell Biol Int; 2013 Mar; 37(3):197-202. PubMed ID: 23364919
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory roles of miR-320 in osteosarcoma via regulating E2F1.
Wu H; Li W; Zhang M; Zhu S; Zhang D; Wang X
J Cancer Res Ther; 2016 Oct; 12(Supplement):68-71. PubMed ID: 27721258
[TBL] [Abstract][Full Text] [Related]
15. Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.
Yoda S; Soejima K; Hamamoto J; Yasuda H; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Naoki K; Betsuyaku T
Lung Cancer; 2014 Sep; 85(3):366-72. PubMed ID: 25001509
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
[TBL] [Abstract][Full Text] [Related]
17. Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.
Olbromski M; Rzechonek A; Grzegrzolka J; Glatzel-Plucinska N; Chachaj A; Werynska B; Podhorska-Okolow M; Dziegiel P
Oncol Rep; 2018 Jan; 39(1):201-208. PubMed ID: 29115529
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
19. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
[TBL] [Abstract][Full Text] [Related]
20. Xenosensor CAR mediates down-regulation of miR-122 and up-regulation of miR-122 targets in the liver.
Kazantseva YA; Yarushkin AA; Mostovich LA; Pustylnyak YA; Pustylnyak VO
Toxicol Appl Pharmacol; 2015 Oct; 288(1):26-32. PubMed ID: 26171734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
